Ellenbogen KA - Search Results

1

Gilligan DM, Ellenbogen KA, Epstein AE. Gilligan DM, et al. Among authors: ellenbogen ka. Am J Med. 1996 Oct;101(4):413-21. doi: 10.1016/S0002-9343(96)00194-5. Am J Med. 1996. PMID: 8873513

2

Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study.

Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ. Epstein AE, et al. Among authors: ellenbogen ka. Circulation. 1992 Oct;86(4):1206-16. doi: 10.1161/01.cir.86.4.1206. Circulation. 1992. PMID: 1394927 Clinical Trial.

3

Role of calcium antagonists for heart rate control in atrial fibrillation.

Ellenbogen KA. Ellenbogen KA. Am J Cardiol. 1992 Mar 6;69(7):36B-40B. doi: 10.1016/0002-9149(92)91348-8. Am J Cardiol. 1992. PMID: 1543141 Review.

4

A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study.

Ellenbogen KA, Dias VC, Plumb VJ, Heywood JT, Mirvis DM. Ellenbogen KA, et al. J Am Coll Cardiol. 1991 Oct;18(4):891-7. doi: 10.1016/0735-1097(91)90743-s. J Am Coll Cardiol. 1991. PMID: 1894861 Free article. Clinical Trial.

5

New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing.

Ellenbogen KA, Thames MD, Mohanty PK. Ellenbogen KA, et al. Am J Cardiol. 1990 Jan 1;65(1):53-9. doi: 10.1016/0002-9149(90)90025-v. Am J Cardiol. 1990. PMID: 1967200

6

Increase in plasma atrial natriuretic factor during ventriculoatrial pacing.

Ellenbogen KA, Kapadia K, Walsh M, Mohanty PK. Ellenbogen KA, et al. Am J Cardiol. 1989 Jul 15;64(3):236-7. doi: 10.1016/0002-9149(89)90467-0. Am J Cardiol. 1989. PMID: 2525872 No abstract available.

7

Atrial natriuretic factor release is enhanced by incremental atrial pacing.

Ellenbogen KA, Mohanty PK, Sowers JR, Walsh M, Thames MD. Ellenbogen KA, et al. Am Heart J. 1988 Aug;116(2 Pt 1):489-96. doi: 10.1016/0002-8703(88)90622-9. Am Heart J. 1988. PMID: 2969668

8

Increased circulating atrial natriuretic factor (ANF) release during induced ventricular tachycardia.

Ellenbogen KA, Rogers R, Walsh M, Mohanty PK. Ellenbogen KA, et al. Am Heart J. 1988 Nov;116(5 Pt 1):1233-8. doi: 10.1016/0002-8703(88)90445-0. Am Heart J. 1988. PMID: 2973214

9

Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.

Stambler BS, Gottlieb SS, Singh BN, Ramanathan KB, Ogilby JD, Ellenbogen KA. Stambler BS, et al. Among authors: ellenbogen ka. J Am Coll Cardiol. 1995 Dec;26(7):1679-84. doi: 10.1016/0735-1097(95)00376-2. J Am Coll Cardiol. 1995. PMID: 7594103 Free article. Clinical Trial.

10

Late occurrence of incessant atrial tachycardia following the maze procedure.

Ellenbogen KA, Hawthorne HR, Belz MK, Stambler BS, Cherwek ML, Wood MA. Ellenbogen KA, et al. Pacing Clin Electrophysiol. 1995 Feb;18(2):367-9. doi: 10.1111/j.1540-8159.1995.tb02528.x. Pacing Clin Electrophysiol. 1995. PMID: 7731886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

752 results

Search Page

Filters